drugset
drugset / Trial / NCT03040128

Use of Minocycline in Intracerebral Hemorrhage

NCT03040128 ↗

Phase 1/2 Completed 20 enrolled University of Tennessee University of Southern California · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To date, no neuroprotective drugs have demonstrated clinical efficacy in intracerebral hemorrhage (ICH). This study will use intravenous (IV) minocycline in ICH to evaluate for (1) safety/ tolerability and (2) evaluate for clinical efficacy

Timeline

Start
2013-06-27
Primary completion
2016-11-30
Completion
2016-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule — Intravenous

Indications

intracerebral hemorrhage